Vanderbilt Scholars in T4 Translational Research (V-STTaR) Program

范德比尔特 T4 转化研究学者 (V-STTaR) 计划

基本信息

批准号：
10241357
负责人：
SUNIL KRIPALANI
金额：
$ 40.68万
依托单位：
VANDERBILT UNIVERSITY MEDICAL CENTER
依托单位国家：
美国
项目类别：
财政年份：
2017
资助国家：
美国
起止时间：
2017-09-01 至 2023-08-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/10241357
关键词：
Academic Medical Centers Active Learning Advisory Committees Americas Award Blood Cardiovascular system Certification Clinical Clinical Research Clinics and Hospitals Development Plans Doctor of Philosophy Environment Extramural Activities Faculty Fellowship Funding Goals Grant Health Health Sciences Heart Heart Diseases Hematological Disease Hematology Intervention Journals Laboratories Lung Lung diseases Master of Public Health Medicine Mentors Mentorship Recording of previous events Research Research Project Grants Resources Scientist Series Site Sleep Sleep Disorders Societies Talents Training Translational Research Translations United States National Institutes of Health career career development clinical center community clinic design experience faculty mentor implementation research implementation science improved medical schools next generation peer coaching population health programs recruit

项目摘要

Project Summary Major gaps exist in the widespread implementation of proven clinical interventions into practice, which greatly limits the positive health impact of scientific discoveries. This new application seeks to establish the Vanderbilt Scholars in T4 Translational Research (V-STTaR) Program, to help train the next generation of implementation scientists to advance and improve population health in heart, lung, blood, and sleep (HLBS) disorders. We propose to support 5 faculty Scholars who have completed an MD or PhD in the health sciences at a level of 75% effort for 3 years, or until they successfully transition to an extramural award. Vanderbilt has an extremely strong environment and successful history of developing the careers of translational research scientists. A diverse pool of talented applicants is available through Vanderbilt's clinical/translational T32 grants; clinical/research fellowships in cardiovascular, pulmonary, hematology, and sleep medicine; the VA Quality Scholars Fellowship (eight national sites including one in Nashville); research partners including Meharry Medical College; and recruitment through national organizations. V-STTaR Scholars will have access to a cadre of well-established faculty mentors with sustained NIH funding and an extensive and successful track record of mentoring early career scholars. Each Scholar's Research Advisory Committee will draw from an experienced pool of 27 mentors in HLBS research and T4 translation, as well as 12 experts in real-world implementation (ImpleMentors). The program will have 3 major components: 1) advanced didactics, including a new Certificate in Implementation Science offered through the established Master of Public Health (MPH) program; 2) formal mentorship and career development activities designed to prepare Scholars for a competitive academic research career in HLBS T4 research; and 3) experiential learning through a closely- mentored implementation research project. Each Scholar will have an individualized development plan with milestones, tailored to their scientific background, training needs, and career goals. V-STTaR Scholars will have access to a diverse clinical laboratory for their implementation research projects through Vanderbilt University Medical Center and its partnerships across the Vanderbilt Health Affiliated Network, community clinics, and Hospital Corporation of America (HCA). Scholars will be supported by a broad array of institutional resources for career development, including the Center for Clinical Quality and Implementation Research scholarly series, journal clubs, work-in-progress sessions, clinical and translational research seminars through the Newman Society (a professional group for all career development awardees at Vanderbilt), and peer mentoring activities with other successful K awardees. Taken together, these resources provide an optimal environment for developing the next generation of independent scientists who conduct T4 translational research in HLBS disorders and close the gap between evidence and practice.

项目概要在将经过验证的临床干预措施广泛实施到实践中存在重大差距，这极大地影响了限制了科学发现对健康的积极影响。这项新申请旨在建立范德比尔特 T4 转化研究学者 (V-STTaR) 计划，帮助培养下一代实施科学家促进和改善人口的心、肺、血液和睡眠健康 (HLBS) 失调。我们建议支持 5 名已完成健康科学医学博士或博士学位的教员学者三年内保持 75% 的努力水平，或者直到他们成功过渡到校外奖励。范德比尔特有发展转化研究事业的极其强大的环境和成功的历史科学家。通过范德比尔特的临床/转化 T32 可以找到各种各样的才华横溢的申请者补助金；心血管、肺、血液学和睡眠医学领域的临床/研究奖学金；弗吉尼亚州优质学者奖学金（八个国家站点，其中一个位于纳什维尔）；研究伙伴包括梅哈里医学院；以及通过国家组织进行招聘。 V-STTaR 学者将有机会获得拥有一支由 NIH 持续资助和广泛且成功的经验丰富的教师导师组成的骨干队伍指导早期职业学者的记录。每位学者的研究咨询委员会将选自由 27 名 HLBS 研究和 T4 翻译领域经验丰富的导师以及 12 名现实世界专家组成实施（ImpleMentors）。该计划将包含 3 个主要组成部分：1）高级教学法，包括通过已建立的公共卫生硕士（MPH）提供新的实施科学证书程序; 2) 旨在帮助学者做好准备的正式指导和职业发展活动 HLBS T4 研究中具有竞争力的学术研究生涯； 3）通过密切的体验式学习指导实施研究项目。每位学者都会有一个个性化的发展计划根据他们的科学背景、培训需求和职业目标量身定制的里程碑。 V-STTaR 学者将可以通过范德比尔特大学使用多样化的临床实验室来实施研究项目大学医学中心及其在范德比尔特健康附属网络、社区中的合作伙伴诊所和美国医院公司 (HCA)。学者们将得到广泛的机构支持职业发展资源，包括临床质量和实施研究中心学术系列、期刊俱乐部、正在进行的会议、临床和转化研究研讨会纽曼协会（范德比尔特大学所有职业发展获奖者的专业团体）和同行与其他成功的 K 获奖者一起开展指导活动。总而言之，这些资源提供了最佳的培养下一代进行 T4 转化的独立科学家的环境 HLBS 疾病的研究，缩小证据与实践之间的差距。

项目成果

期刊论文数量（36）

专著数量（0）

科研奖励数量（0）

会议论文数量（0）

专利数量（0）

Investigating N-3 Fatty Acids to prevent Neonatal Tobacco-related outcomeS (INFANTS): study protocol for a double-blind, randomized, placebo-controlled parallel clinical trial of n-3 polyunsaturated fatty acids in pregnant smokers.

DOI：
10.1186/s13063-021-05865-7
发表时间：
2021-12-14
期刊：
Trials
影响因子：
2.5
作者：
Murff HJ;Greevy RA;Sanghani RS;Hartmann KE;Hartert TV;Graves CR;Lee SS;Tindle HA
通讯作者：
Tindle HA

An International Study Exploring the Experience of Survivors of Critical Illness as Volunteers Within ICU Recovery Services.

DOI：
10.1097/cce.0000000000000273
发表时间：
2020-11-01
期刊：
Critical care explorations
影响因子：
0
作者：
Robinson, Carly;Hibbert, Elizabeth;Boehm, Leanne M
通讯作者：
Boehm, Leanne M

Cigarette Smoking and Risk Perceptions During the COVID-19 Pandemic Reported by Recently Hospitalized Participants in a Smoking Cessation Trial.

DOI：
10.1007/s11606-021-06913-3
发表时间：
2021-12
期刊：
Journal of general internal medicine
影响因子：
5.7
作者：
Rigotti NA;Chang Y;Regan S;Lee S;Kelley JHK;Davis E;Levy DE;Singer DE;Tindle HA
通讯作者：
Tindle HA

Key Components of ICU Recovery Programs: What Did Patients Report Provided Benefit?